GUÍAS DE PRÁCTICA CLÍNICA Y REVISIONES
COCHRAINE EN ONCOLOGÍA
- MISCELANIA.
- CÁNCER DE CABEZA Y CUELLO.
- LINFOMAS.
- CÁNCER DE LARINGE.
- CÁNCER DE OROFARINGE.
- CÁNCER DE RINOFARINGE.
- CÁNCER DE TIROIDES.
- TUMORES CUÁNEOS ORL.
- CANCERÍGENOS.
- CUIDADOS DEL PACIENTE ONCOLÓGICO.
- DOLOR ONCOLÓGICO.
- QUINMIOTERAPIA
- RADIOTERAPÍA.
2022
ESPEN guideline. Agency for Healthcare Research and Qualit.
2016
The Journal of Laryngology & Otology / Cambridge University Press.
Idioma: INGLÉS
2019
College of American Pathologists. Idioma: INGLÉS
2015
Société Française d’Oto-Rhino-Laryngologie et de Chirurgie de la Face et du Cou. Idioma: FRANCÉS
2002
Agency for Healthcare Research and Quality: US. Idioma: INGLÉS
2020
American Society of Clinical Oncology. Idioma: INGLÉS
American Society of Clinical Oncology. Idioma: INGLÉS
European Society for Medical Oncology. Idioma: INGLÉS
2019
Instituto Guatemalteco de Seguridad Social Subgerencia de Prestaciones en Salud Comisión de Elaboración de Guías de Práctica Clínica Basadas en la Evidencia. Idioma: ESPAÑOL
2017
Sociedad Esapañola de Oncología Médica. Idioma: INGLÉS
2016
Program in Evidence-based Care. Idioma: INGLÉS
Cochrane Library, Group: ENT Group. Idioma: INGLÉS
National Institute for Health and Care Excellence. Idioma: INGLÉS
National Comprehensive Cancer Network. Idioma: INGLÉS
2014
Cancer Care Ontario. Idioma: INGLÉS
2013
Routine HPV Testing in Head and Neck Squamous Cell Carcinoma. Program in Evidence-based Care. Idioma: INGLÉS2012
PET Imaging in Head and Neck Cancer. 2009/2012. Cancer Care Ontario. Idioma: INGLÉS
2011
Cancer Care Ontario. Idioma: INGLÉS
2010
Grupo español de tratamiento de tumores de cabeza y cuello: TTCC.
National Institute for Health and Care Excellence. Idioma: INGLÉS
ESMO Guidelines Working Group. Idioma: INGLÉS
2009
Cancer Care Ontario.
2004
National Institute for Health and Care Excellence.
2018
Centro Nacional de Excelencia Tecnologia en Salud, México.
Idioma: ESPAÑOL
2016
National Institute for Health and Care Excellence.
2015
Subsecretaría de Salud Pública DIPRECE Departamento Manejo integral de Cáncer y otros Tumores. Chile. Idioma: ESPAÑOL
2009
Haute Autorité de Santé, Institut National du Cancer.
Idioma: FRANCÉS
2021
Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. The European Reference Networks (ERNs).
2017
Grupos Cooperativos Oncología Médica. Idioma: INGLÉS
2016
Malaysia Health Technology Assessment Section: MaHTAS.
2015
American College of Radiology.
Saskatchewan Cancer Agency.
2013
CancerControl Alberta.
CÁNCER DE TIROIDES.
Medical/Surgical Guidelines for Clinical Practice for Management of Thyroid Carcinoma. 2001 (American Association of Clinical Endocrinologist and American Thiroid Association).
2021
American Thyroid Association. Idioma: INGLÉS
2017
Société Française d’Oto Rhino Laryngologie et de Chirurgie de la Face et du Cou. idioma: FRANCÉS
U.S. Preventive Services Task Force.
2015
American Thyroid Association.
2013
Fisterra.
National Comprehensive Cancer Network.
2019
American Thyroid Association.
2016
American Thyroid Association.
2004
U.S. Preverntive Service Task Force.
Société Française d’Oto Rhino Laryngologie et de Chirurgie de la Face et du Cou.
2001
Medical/Surgical Guidelines for Clinical Practice for Management of Thyroid Carcinoma. 2001 (American Association of Clinical Endocrinologist and American Thiroid Association).2021
American Academy of Dermatology, American Academy of Fcacial Plastic and Reconsructive Surgery, American Academy of Otolaryngology - Head and Neck Surgery Foundation, American Society for Dermatologic Surgery, American Society of Plastic Surgeons. Idioma: INGLÉS
2019
Instituto Mexicano del Seguro Social. Idioma: ESPAÑOL
American Academic of Pediatric. Idioma: INGLÉS
2018
2017
Health Care Program, Agency for Healthcare Research and Quality.
Idioma: INGLÉS
2014
The Effective Health Care. Agency for Healhcare Research and Quality.
Idioma: INGLÉS
American College of Radiology.
2016
Canadian Paediatric Society.
2012
Scientific Standards for Studies on Modified Risk Tobacco Products. National Research Council.2008
Agency for Healthcare Research and Quality.
2004
Agencia de Evaluciçón de Tecnologías Sanitarias de Andalucia.
1994
Centers for Disease Control and Prevention.
Centers for Disease Control and Prevention.
1993
Centers for Disease Control and Prevention.
1992
Centers for Disease Control and Prevention.
1991
Centers for Disease Control and Prevention.
National Institute for Occupational Health.
1990
The Health Benefits of Smoking Cessation: A report of the Surgeon General . 1990 (Centers for Disease Control and Prevention).1989
Centers for Disease Control and Prevention.
1985
Centers for Disease Control and Prevention.
2018
Fisterra.
2016
Cochrane Library, Primary Review Gropu: ENT Group.
American Cancer Society.
Fisterra.
2015
Société Française d’Oto-Rhino-Laryngologie et de Chirurgie de la Face et du Cou.
Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis. 2013 (National Academy of Sciences). Modelos organizativos en cuidados paliativos. Comparación de consumo de recursos. 2009 (Agencia de Evaluación de Tecnología Sanitaria de andalucia). ACS Releases Long-term Care Guideline for Survivors of Head and Neck Cancer. 2006 (American Cancer Society). Improving outcomes in head and neck cancers. 2004 (National Institute for Health and Care Excellence). NIH State-of-the-Science Conference on Improving End-of-Life Care. 2004 (National Institutes of Health. Consensus Development Conference Statement). Oral & Dental Care. 2003 (BC Cancer Agency Dental Clinic). Symptom Management in Cancer: Pain, Depression, and Fatigue. 2002 (National Institutes of Health. Consensus Development Conference Statement). Oral Complications of Cancer Therapies: Diagnosis, Prevention, and Treatment. 1989 (National Institutes of Health. Consensus Development Conference Statement).2021
American Academy of Otolaryngology–Head and Neck Surgery Foundation,
Idioma: INGLÉS
2020
Revista Médica Sanitas. Idioma: ESPAÑOL
2014
Prise en charge des douleurs somatiques induites par les traitements des cancers des VADS . 2014 (Société Française d’Oto-Rhino-Laryngologie et de Chirurgie de la Face et du Cou). Idioma: FRANCÉS 2010
Malaysia Health Technology Assessment Section:MaHTAS. Idioma: INGLÉS
2008
Scottish Intercollegiate Guidelines Network. Idioma: INGLÉS
2001
Agency for Healthcare Research and Quality: US. Idioma: INGLÉS
1994
AHCPR Clinical Practice Guidelines, No. 9. Agency for Health Care Policy and Research (AHCPR). Idioma: INGLÉS
2016
Cochrane Childhood Cancer Group. Idioma: INGLÉS
Cochrane Childhood Cancer Group. Idioma: INGLÉS
Platinum-induced hearing loss after treatment for childhood cancer. 2016 (Cochrane Childhood Cancer Group). Idioma: INGLÉS Radioterapia paliativa. 2017 (Fisterra). Modern radiotherapy techniques versus three-dimensional conformal radiotherapy for head and neck cancer. 2017 (Cochrane Library, Primary Review Gropu: ENT Group). Radiotherapy Treatments for Head and Neck Cancer Update. Comparative Effectiveness Review, No. 144. 2014 (Agency for Healthcare Research and Quality: US). Mucositis en el paciente oncológico. 2013 (Fisterra). Appropriateness Criteria® retreatment of recurrent head and neck cancer after prior definitive radiation. 2010 (American College of Radiology). Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer. Comparative Effectiveness Reviews, No. 20. 2010 (Agency for Healthcare Research and Quality: US). Updated clinical practice guidelines for the prevention and treatment of mucositis. 2007 Síontesis amplia / Guía. Clinical practice guidelines for the management of mucositis secondary to cancer therapy. 2004 (International Society for Oral Oncology; Multinational Association of Supportive Care in Cancer). Symptomatic Treatment of Radiation-Induced Xerostomia in Head and Neck Cancer Patients . 2004 (Cancer Care Ontario). Hyperfractionated Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck. 2003 (Cancer Care Ontario). Accelerated Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck. 2000 (Cancer Care Ontario).
TÉRMINOS RELACIONADOS: